Why SARS-CoV-2 replicates better in the upper respiratory tract

What happens in our airways after infection with SARS-CoV-2? Researchers from the Institute of Infectious Diseases (IFIK) at the University of Bern and the Swiss Federal Institute of Virology and Immunology (IVI) have been able to show how the virus replicates in the respiratory tract and how the innate immune response there reacts. The findings can be used to develop antiviral drugs and preventive measures.

Link to the webpage of the University of Bern:

Results of 501Y mutation screening by RT-PCR of SARS-CoV-2 positive samples analyzed at IFIK.

Unique biosafety laboratory in Switzerland up and running